By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Cipaglucosidase Alfa
Drugs

Cipaglucosidase Alfa

https://themeditary.com/drug/cipaglucosidase-alfa-23145.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Mar 01, 2024  Additional Content by TheMediTary.Com

Pregnancy & Lactation: Risk data not available

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Cipaglucosidase Alfa?

Cipaglucosidase alfa is used in combination with Opfolda (miglustat) to treat late-onset Pompe disease in adults who weigh at least 88 pounds (40 kg), and when enzyme replacement therapy did not work or stopped working.

Cipaglucosidase alfa may also be used for purposes not listed in this medication guide.

Warnings

Tell your doctor if you have or have ever had:

  • fluid retention;
  • heart problems; or
  • lung disease or breathing problems.

People with severe heart or respiratory problems or prone to fluid retention may have a higher risk of their condition worsening. Talk to your doctor about your risk.

May harm an unborn baby. Do not use if you are pregnant. You will need to have a negative pregnancy test before starting this treatment. Use effective birth control while receiving this treatment and for at least 60 days after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed while receiving this medicine.

When used together with Opfolda (miglustat), cipaglucosidase alfa may affect fertility in men or women. Pregnancy could be harder to achieve while either parent is using this medicine.

How should I use Cipaglucosidase Alfa

Use Cipaglucosidase Alfa (Intravenous) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Follow all directions on your prescription label and read all medication guides or instruction sheets. Cipaglucosidase alfa must be administered together with Opfolda (miglustat).

Your doctor will stop your other treatments for Pompe disease before your first dose of cipaglucosidase alfa. Follow your doctor's dosing instructions very carefully.

Make sure you take Opfolda (miglustat) 1 hour before receiving cipaglucosidase alfa.

You will receive cipaglucosidase alfa as an infusion into a vein about 1 hour after you take Opfolda (miglustat). A healthcare provider will give you this injection every other week.

Your breathing, blood pressure, oxygen levels, and other vital signs will be watched closely to make sure you do not have serious side effects.

You may be given other medications to help prevent or treat serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.

Doses are based on weight. Your dose may change if you gain or lose weight.

What should I do if I missed a dose of Cipaglucosidase Alfa (Intravenous)?

You must take Opfolda (miglustat) before receiving cipaglucosidase alfa injection. Call your doctor for instructions if you skip an Opfolda dose or miss an appointment for the injection.

Cipaglucosidase Alfa side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Some people have a severe reaction to cipaglucosidase alfa. These side effects may occur during or within a few hours after the injection. Tell your medical caregiver if you feel dizzy, nauseated, itchy, sweaty, light-headed, have a headache, chest pain or tightness, back pain, chills, swelling, or trouble breathing.

Also tell your medical caregivers right away if you have:

  • slow heart rate, weak pulse, fainting, slow breathing (breathing may stop).

Common side effects may include:

  • headache, weak or tired feeling;
  • diarrhea, nausea, stomach pain; or
  • fever.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Cipaglucosidase Alfa?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

More about Cipaglucosidase Alfa

Drug images
Side effects
Drug class: Drugs
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by